|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/10/17 Evolutionary Genomics, Inc. 10-K 12/31/16 66:3.8M Edgar Filing LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Quarterly Report HTML 519K
3: EX-10.10 Agreement Amendment #2 HTML 37K
2: EX-10.9 Agreement Amendment #1 HTML 23K
4: EX-21.1 Subsidiaries List HTML 18K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 19K
15: R1 Document and Entity Information HTML 46K
16: R2 Consolidated Balance Sheets HTML 94K
17: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K
18: R4 Consolidated Statements of Operations HTML 62K
19: R5 Consolidated Statement of Stockholders' Equity HTML 62K
20: R6 Consolidated Statements of Cash Flows HTML 84K
21: R7 Business Activity HTML 25K
22: R8 Summary of Significant Accounting Policies HTML 35K
23: R9 New Accounting Standards HTML 31K
24: R10 Fair Value Measurements HTML 43K
25: R11 Property and Equipment HTML 32K
26: R12 Intangible Assets HTML 31K
27: R13 Income Taxes HTML 50K
28: R14 Stockholders' Equity and Warrants HTML 52K
29: R15 Stock-Based Compensation HTML 68K
30: R16 Commitments and Contingencies HTML 26K
31: R17 Related Parties and Transactions HTML 23K
32: R18 Concentrations HTML 24K
33: R19 Agreement and Plan of Merger HTML 41K
34: R20 Summary of Significant Accounting Policies HTML 87K
(Policies)
35: R21 Fair Value Measurements (Tables) HTML 38K
36: R22 Property and Equipment (Tables) HTML 30K
37: R23 Intangible Assets (Tables) HTML 28K
38: R24 Income Taxes (Tables) HTML 48K
39: R25 Stockholders' Equity and Warrants (Tables) HTML 40K
40: R26 Stock-Based Compensation (Tables) HTML 66K
41: R27 Agreement and Plan of Merger (Tables) HTML 35K
42: R28 Business Activity (Details) HTML 27K
43: R29 Summary of Significant Accounting Policies (Other) HTML 24K
(Details)
44: R30 Summary of Significant Accounting Policies HTML 24K
(Property and Equipment) (Details)
45: R31 Summary of Significant Accounting Policies HTML 23K
(Intangilbe Assets) (Details)
46: R32 Summary of Significant Accounting Policies HTML 24K
(Investment in VetDC, Inc.) (Details)
47: R33 Summary of Significant Accounting Policies (Net HTML 29K
Loss Per Common Share) (Details)
48: R34 Fair Value Measurements (Details) HTML 32K
49: R35 Property and Equipment (Details) HTML 37K
50: R36 Intangible Assets (Details) HTML 48K
51: R37 Income Taxes (Narrative) (Details) HTML 29K
52: R38 Income Taxes (Income Tax Reconciliation) (Details) HTML 42K
53: R39 Income Taxes (Schedule of Deferred Tax Assets and HTML 42K
Liabilities) (Details)
54: R40 Stockholders' Equity and Warrants (Narrative) HTML 38K
(Details)
55: R41 Stockholders' Equity and Warrants (Summary of HTML 43K
Warrants Activity) (Details)
56: R42 Stock-Based Compensation (Narrative) (Details) HTML 45K
57: R43 Stock-Based Compensation (Summary of Stock Options HTML 57K
Activity) (Details)
58: R44 Commitments and Contingencies (Details) HTML 27K
59: R45 Related Parties and Transactions (Details) HTML 23K
60: R46 Concentrations (Details) HTML 30K
61: R47 Agreement and Plan of Merger (Narrative) (Details) HTML 46K
62: R48 Agreement and Plan of Merger (Purchase Price HTML 30K
Allocation) (Details)
63: R49 Agreement and Plan of Merger (Unaudited Proforma HTML 25K
Information) (Details)
65: XML IDEA XML File -- Filing Summary XML 111K
64: EXCEL IDEA Workbook of Financial Reports XLSX 51K
9: EX-101.INS XBRL Instance -- fnam-20161231 XML 735K
11: EX-101.CAL XBRL Calculations -- fnam-20161231_cal XML 139K
12: EX-101.DEF XBRL Definitions -- fnam-20161231_def XML 279K
13: EX-101.LAB XBRL Labels -- fnam-20161231_lab XML 680K
14: EX-101.PRE XBRL Presentations -- fnam-20161231_pre XML 511K
10: EX-101.SCH XBRL Schema -- fnam-20161231 XSD 102K
66: ZIP XBRL Zipped Folder -- 0001553350-17-000164-xbrl Zip 83K
| Certification |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Evolutionary Genomics, Inc. (the "Company") on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve B Warnecke, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
BY: | /s/ Steve B Warnecke |
| |
| Chief Financial Officer |
| (principal financial officer) |
|
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/10/17 | None on these Dates | ||
| For Period end: | 12/31/16 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/09/23 Evolutionary Genomics, Inc. 10-K 12/31/22 58:3.3M Edgar Filing LLC/FA 3/22/22 Evolutionary Genomics, Inc. 10-K 12/31/21 56:3.2M Edgar Filing LLC/FA 3/31/21 Evolutionary Genomics, Inc. 10-K 12/31/20 61:3.3M Edgar Filing LLC/FA |